Previous Article | Next Article ![]()
Journal of Bacteriology, December 2003, p. 7257-7265, Vol. 185, No. 24
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.24.7257-7265.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
and Brian M. M. Ahmer*
Department of Microbiology, The Ohio State University, Columbus, Ohio 43210-1292
Received 31 July 2003/ Accepted 17 September 2003
|
|
|---|
|
|
|---|
The focus of
this report is the SirA/BarA two-component regulatory system, which is
one of several evolutionarily conserved housekeeping systems that
regulate SPI1 (2,
5,
33). SirA orthologs are
present, with different names, throughout the
-proteobacteria,
e.g., SirA in S. enterica serovar Typhimurium, GacA
in Pseudomonas species, VarA in Vibrio
cholerae, ExpA in Erwinia carotovora, LetA
in Legionella pneumophila, and UvrY in
Escherichia coli
(29). In each species,
sirA is located directly upstream of uvrC but is not
involved in UvrC functions (DNA repair). A sensor kinase for SirA is
present in each of these organisms as well. The sensor kinase is known
as BarA in E. coli and Salmonella but has
different names in other genera (GacS, ExpS, and LetS). In S.
enterica serovar Typhimurium, SirA positively regulates the
invasion of tissue culture cells and bovine gastroenteritis while
negatively affecting the expression of flagellar genes
(2,
5,
24,
33). In other species,
sirA/barA orthologs are required for virulence gene
expression, exoenzyme and antibiotic production, motility, and biofilm
formation
(29).
SirA is a response regulator of the FixJ family (29). It is predicted to have a C-terminal DNA binding domain (helix-turn-helix) and an N-terminal phosphoacceptor domain. BarA is the sensor kinase for SirA, as determined on the basis of biochemical data generated with E. coli (55) and genetic data generated with Salmonella, Erwinia, and Pseudomonas (5, 17, 29, 70). BarA has a predicted secondary structure similar to those of the BvgS family of hybrid sensor kinases, which contain both receiver and transmitter domains. BarA is predicted to have two transmembrane alpha helices at the N terminus followed by a cytosolic transmitter domain containing a conserved histidine residue, a central receiver domain containing a conserved aspartate residue and, finally, a phosphotransfer domain containing a conserved histidine residue (29, 70).
SPI1 is a Salmonella-specific horizontal acquisition, the expression of which is controlled by numerous housekeeping regulators located throughout the Salmonella chromosome. The primary "adaptor" regulator that links the endogenous sensory capabilities of the cell to SPI1 gene expression is hilA (7). HilA is a member of the OmpR/ToxR family that is encoded within SPI1. However, HilA lacks the phosphoryl acceptor domain typical of other OmpR family members, and its activity is probably not modulated by posttranslational modification. Instead, HilA appears to be a constitutive activator that is controlled primarily at the level of transcription (7).
Numerous genes have been identified as having either positive or negative effects on hilA expression. Positive influences include sirA/barA, the posttranscriptional regulatory system consisting of csrA and csrB, and other genes, including fis, fadD, fliZ, ompR/envZ, hilC (sirC or sprA), and hilD (2-4, 16, 18, 33, 48, 53, 56, 58, 66). Negative influences include hilE, the two-component regulatory systems phoP/phoQ and phoB/phoR, the lon protease, ams (RNase E), hupB (HU), and the histone-like protein Hha (8-10, 18, 19, 48, 62). The hilC and hilD genes both encode AraC-type regulators. These two genes differ from the others in that they are Salmonella specific and are located within SPI1. The determination of which genes encode direct regulators of hilA and which have indirect effects has begun only recently. To date, it is known that the positive regulators HilC and HilD and the negative regulators Hha and Fis can bind directly the hilA promoter (8, 19, 53, 59).
Once HilA is produced, it directly activates two operons encoding the type III secretory apparatus, the prgH operon and the invF operon. The prgH operon includes prgHIJK-orgABC, and the invF operon includes invFGEABC-spaMNOPQRS-sicA-sipBCDA-iacP-sicP-sptP. InvF is a transcription factor that activates genes encoding secreted effectors (12-14). The secreted effectors are expressed at higher levels than the structural apparatus, so InvF appears to act as an "amplifier" of HilA activity. Within SPI1, InvF activates sipBCDA and downstream genes by binding to an internal promoter upstream of sicA. The sipBCD genes encode secreted effectors that are themselves required for the translocation of other effectors into the host cell and probably form a translocase complex in the target cell membrane (31). At least six effectors are encoded outside of SPI1. They are encoded by sopA, sopD, slrP, sopE, sopE2, and sopB (sigD) (68). The sopB and sopE genes are known to be regulated by invF (12, 14).
Interestingly, in addition to binding the hilA promoter, both the HilC and the HilD proteins can directly bind the invF promoter in vitro, providing the ability to bypass the hilA requirement (3). While the hilD gene is essential for hilA expression, the hilC gene is not (16, 47, 56). Although a hilC mutation had very little impact on invasion gene expression under the conditions tested, hilC is known to be regulated by SirA, and the plasmid-based expression of hilC can lead to invasion gene expression in the absence of hilA (3, 56).
In addition to regulating virulence gene expression, sirA orthologs affect flagellar gene expression and/or motility in E. coli, S. enterica serovar Typhimurium, Pseudomonas fluorescens, Pseudomonas aeruginosa, and Vibrio cholerae (24). Swarming motility in Pseudomonas syringae also requires sirA/barA orthologs (36). Flagellar biosynthesis has been divided into three levels (11). The class 1 operon encodes two proteins, FlhD and FlhC. These form a heterotetramer that is required for the transcriptional activation of class 2 genes, which encode hook-basal body complexes and the alternative sigma factor FliA. The FliA sigma factor allows the expression of class 3 genes, which encode the filament protein, hook-associated proteins, motor proteins, and chemotaxis proteins (38, 39).
In both E. coli and S. enterica serovar Typhimurium, the flhDC promoter is a major point of signal integration. Transcription from this promoter is regulated by numerous conditions and regulators, including DNA supercoiling, temperature, growth phase, cell cycle, cyclic AMP receptor protein, OmpR, H-NS, HdfR, and LrhA (11, 37, 44). Posttranscriptionally, the flhDC transcript is stabilized by CsrA (65).
CsrA is a small RNA binding protein that controls bacterial gene expression at the level of transcript stabilization (57). Depending on the target gene, CsrA either can stabilize transcripts and promote translation or can bind near the ribosome binding site to block translation and stimulate message decay. The csrB gene encodes a regulatory RNA that can bind up to 18 CsrA proteins and antagonize CsrA function (57). The csrB gene was recently discovered to be regulated by the SirA ortholog of E. coli, UvrY (61). In S. enterica serovar Typhimurium, the CsrA/csrB system is capable of both positively and negatively regulating the virulence genes located within SPI1 (4, 5). The effects are partially mediated through hilA, but this mediation may be indirect and may involve the regulation of hilC or hilD. Additionally, csrA can continue to affect invF and sipC, but not prgH, in the absence of hilA, indicating that CsrA may directly affect the posttranscriptional regulation of multiple invasion genes (4).
In this report, we focus on the pathways leading to SirA-dependent regulation of Salmonella virulence (the HilA regulon, which includes SPI1, and the sopB gene within SPI5) and flagellar genes (the FlhDC regulon). Using both genetic and biochemical approaches, we demonstrate that SirA regulates motility and virulence through independent pathways.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains
and plasmids used
|
DNA manipulations and genetic techniques. DNA manipulations were performed by standard techniques (49a),typically with TOP10 as the recipient E. coli strain (Invitrogen, Carlsbad, Calif.). Restriction enzymes were purchased from Life Technologies (Rockville, Md.). Oligonucleotides were synthesized by IDT Technologies (Coralville, Iowa). Plasmid DNAs were prepared and DNA fragments were isolated from agarose gels by using the appropriate Qiagen (Valencia, Calif.) kits (QIAprep spin miniprep kit and QIAquick gel extraction kit, respectively) according to the protocols of the supplier. Electroporation of S. enterica serovar Typhimurium was achieved by using a Gene Pulser II system (Bio-Rad, Hercules, Calif.). Transduction performed with phage P22 HTint was followed by streaking for isolation on LB-EGTA agar plates containing appropriate antibiotics and by confirming smooth lipopolysaccharide and lack of pseudolysogeny on Evans blue-uranine plates as described previously (49). Mobilization of suicide vectors from E. coli to Salmonella was performed by mixing 50 µl each of stationary-phase cultures of the donor and the recipient and plating the samples on LB agar overnight at 37°C. On the following day, the bacteria were scraped from the LB plate, resuspended in M9 minimal glucose medium, and plated on M9 minimal glucose plates containing kanamycin. We have determined that the pir-dependent suicide vector pVIK112 (35), which creates lacZYA transcriptional fusions, can persist in Salmonella in the absence of a promoter fragment cloned upstream of lacZYA. Presumably, the plasmid is integrated in a region of the genome that is homologous to the vector, but this notion has not been investigated. However, all chromosomal merodiploid fusions constructed with pVIK112 were confirmed to have been integrated into the correct sites by using PCR with a primer designed to bind the Salmonella chromosome upstream of the cloned promoter region and another primer that binds the lacZ gene of the vector. Regulatory mutations were then transduced into the proper fusion strain with phage P22 HTint.
Plasmid constructions. Plasmid pBA322 was constructed by removing the sirA fragment of pJVR4 with XbaI and SacI and cloning the fragment into pBAD18-kn digested with XbaI and SacI. Plasmid pMT6 was constructed by amplifying the csrA promoter region (nucleotides [nt] 1398 to 1704 of a sequence with GenBank accession number AE008829) with Taq DNA polymerase (GeneChoice, Frederick, Md.), cloning the fragment into pCR2.1-TOPO (Invitrogen), removing the fragment with EcoRI, and inserting it into the EcoRI site of pVIK112. Plasmid pRG61 was constructed by amplifying the sopB promoter region (nt 4 to 657 of a sequence with accession number AF021817) with Pfu Turbo DNA polymerase (Stratagene, La Jolla, Calif.), cloning the fragment into pCR-Blunt II-TOPO (Invitrogen), removing the fragment with EcoRI, and inserting it into the EcoRI site of pSB377. Plasmid pRG84 was constructed by amplifying the csrB promoter region (nt 1738 to 1984 of a sequence with accession number AF076153) with Pfu Turbo DNA polymerase, cloning the fragment into pCR-Blunt II-TOPO, removing the fragment with EcoRI, and inserting it into the EcoRI site of pVIK112. Plasmid pBA416 was constructed by amplifying sirA (nt 1911 to 2602 of a sequence with accession number U88651; the 3' primer also incorporated an XhoI site) with Pfu DNA polymerase (Stratagene), cloning the fragment into the SrfI site of pCR-Script AMP (Stratagene), removing the fragment with EcoRI and XhoI, and inserting it into pET24a (Novagen, Madison, Wis.) digested with EcoRI and XhoI. Plasmid pRG67 was constructed by amplifying a fragment of barA lacking the first 198 codons (nt 697 to 2889 of a sequence with accession number AF171069) with Pfu DNA polymerase (Stratagene). The 5' primer included a BamHI site, and the 3' primer included a PstI site. The resulting PCR product was cloned into pCR-Blunt II-TOPO, removed with BamHI and PstI, and cloned into pQE30 (Qiagen) digested with BamHI and PstI.
Purification of
His6-tagged proteins.
E. coli
XL1-Blue/pRG67 (His6-BarA198 [BarA198 is a form of BarA
lacking the two N-terminal membrane-spanning domains]) and
E. coli BL21
DE3/pBA416
(SirA-His6) were grown in 1 liter of broth containing
16 g of tryptone, 10 g of yeast extract, and
5 g of NaCl with appropriate antibiotics
(55). E.
coli BL21
DE3/pBA416 was grown on a rotary shaker at
37°C. At an optical density at 550 nm of 0.5,
isopropyl-ß-D-thiogalactopyranoside (IPTG) was added
to 1 mM, followed by 4 h of shaking incubation at
37°C. E. coli XL1-Blue/pRG67 was grown in a
3-liter jacketed bioreactor (Z61103CT04; Applikon Dependable
Instruments DV, Schiedam, The Netherlands) at 37°C with 500 ml
of air per liter of medium per min of aeration and with agitation at
200 rpm. When the culture reached an optical density at 550 nm of 0.5,
IPTG was added to 1 mM, and incubation was continued overnight at
17°C. Cells from both strains were harvested by centrifugation
and suspended in lysis buffer (50 mM NaH2PO4, 300
mM NaCl, 10 mM imidazole [pH 8.0]) containing 1 mg of
lysozyme/ml and 1 mM protease inhibitor phenylmethylsulfonyl fluoride.
Cells were then disrupted with a French press and mild sonication. The
His6-tagged proteins were purified by nickel affinity
chromatography with nickel resin from Qiagen according to the
manufacturer's instructions. Elution was performed with lysis
buffer containing increasing concentrations of imidazole. The
His6-tagged proteins eluted at between 50 and 200 mM
imidazole. The preparation of His6-BarA198 was dialyzed in a
Slyde-A-Lyzer 7K cassette (Pierce, Rockford, Ill.) overnight in
dialysis buffer (0.1 M Tris-HCl, 30 mM potassium glutamate, 1 mM
dithiothreitol [DTT], 0.5 mM EDTA, 0.5 mM
phenylmethylsulfonyl fluoride, 20% [vol/vol] glycerol
[pH 8.0]) and then concentrated in a spin dialysis unit with
a 30-kDa molecular-mass cutoff (Vivascience, Carlsbad,
Calif.). SirA-His6 was spin dialyzed in a Vivascience spin
dialysis unit (10-kDa molecular-mass cutoff) and then mixed 2:1 with
3x phosphorylation buffer containing 14% glycerol
(55). Protein
concentrations were estimated by using a modified Lowryassay (DC protein assay kit; Bio-Rad) or a bicinchoninic acid protein
assay (Pierce) with serial dilutions of bovine serum albumin (BSA) as a
standard. The protein preparations were stored at
-80°C.
Phosphorylation
and transphosphorylation assays.
Phosphorylation and
transphosphorylation reactions were carried out by using
phosphorylation buffer
(55) with 40 µM
[
-32P]ATP at room temperature (specific
activity, 3,000 Ci/mmol; Perkin-Elmer Life Sciences, Wellesley, Mass.).
The phosphorylation reaction was initiated by the addition of
[
-32P]ATP to 15 µg of
His6-BarA198 in phosphorylation buffer (total volume, 150
µl). Aliquots (15 µl) were removed at various times and
added to an equal volume of 2x LSB (0.09 M Tris-HCl [pH
6.8], 20% [vol/vol] glycerol, 2%
[wt/vol] sodium dodecyl sulfate [SDS], 0.02%
[wt/vol] bromophenol blue, 0.1% [wt/vol]
DTT) to stop the reaction. The transphosphorylation reaction was
initiated by the addition of 30 µg of SirA-His6 to a
150-µl phosphorylation reaction mixture with or without
His6-BarA198. Aliquots (15 µl) were removed at
various times and added to an equal volume of 2x LSB to stop
the reaction. Samples were subjected to SDS-polyacrylamide gel
electrophoresis (PAGE) with 12.5% acrylamide gels. Radioactive
regions of gels were detected with a Storm PhosphorImager (Molecular
Dynamics, Sunnyvale, Calif.) and quantitated with ImageQuant 5.2
software (Molecular Dynamics).
Gel
mobility shift assays.
Promoter regions upstream of
csrA, csrB, flhD, fliA,
hilA, hilC, hilD, and invF were
amplified by PCR with S. enterica serovar Typhimurium
14028 as a template. The DNA fragments spanned nucleotides of sequences
with the following GenBank accession numbers: hilA is nt 550
to 850 of
U25352,
flhD is nt 548 to 850 of
AF029300,
hilC is nt 2146 to 2472 of
AE008831,
hilD is nt 6729 to 7027 of
AE008831,
csrA is nt 1398 to 1704 of
AE008829,
invF is nt
12500 to
12800 of
AE008832,
fliA is nt 250 to 550 of
AB010947,
and csrB is nt 1738 to 1984 of
AF076153.
The DNA fragments were purified by agarose gel electrophoresis followed
by gel extraction with a QIAquick gel extraction kit. A 250-ng quantity
of each fragment was end labeled for 1 h at 37°C with
[
-32P]ATP and T4 polynucleotide kinase
according to the manufacturer's instructions (Boehringer Mannheim,
Indianapolis, Ind.). The labeled fragment was then separated from
unincorporated nucleotides with ProbeQuant G-50 microcolumns (Amersham
Life Sciences, Piscataway, N.J.).
DNA binding reactions were
carried out with a total volume of 20 µl containing 5
µl of 3x DNA binding buffer (129 mM Tris-HCl, 90 mM
potassium acetate, 24 mM MgSO4, 81 mM ammonium acetate, 3 mM
DTT, 240 mM KCl, 30% glycerol; this is a modification of a
buffer from reference
22), 5 µl of
His6-BarA198-SirA-His6
transphosphorylation reaction mixture (as described above except with
nonradioactive ATP), 2 µl of labeled DNA fragment (
5
ng; 54,000 cpm), 2 µl of poly(dI-dC) (1 µg/µl),
1 µl of BSA (1 µg/µl), and 0.5 µl of
0.5 M EDTA. DNA binding reactions were carried out at room temperature
for 25 min, and then samples were subjected to native PAGE with
5% polyacrylamide gels and a buffer containing 90 mM Tris, 90 mM
H3BO3, and 2 mM EDTA. Radioactive regions of gels
were detected with a Storm PhosphorImager and quantitated with
ImageQuant 5.2
software.
|
|
|---|
![]() View larger version (59K): [in a new window] |
FIG. 1. Interactions
among SirA, the FlhD regulon, and the HilA regulon. (A) HilA
expression is positively affected by flhD, and sirA
regulates hilA in the absence of flhD. A
lacZYA fusion to hilA produces more blue pigment in
the wild-type background, BA1550, than in the flhD mutant,
BA460, or the sirA mutant, BA1750. Pigment production
decreases further in an sirA flhD double mutant,
BA461. The plate shown is an LB plate that contained X-Gal and was
incubated at 37°C. (B) A representative member of the
HilA regulon, sopB, is positively affected by flhD,
and sirA regulates sopB in the absence of
flhD. A sopB::luxCDABE
fusion (pRG61) yields more light in the wild-type background, 14028,
than in the flhD mutant, AT351, or the sirA mutant,
BA746 (intensity scale goes from blue [low luminescence] to
red [high luminescence]). Light production decreases further
in an sirA flhD double mutant, RG206. The plate shown
is an LB plate that was incubated at 37°C. (C) SirA
can regulate sopB in an flhD mutant. RG206/pRG61 is
an sirA flhD double mutant carrying a
sopB::luxCDABE fusion on pRG61.
pJVR4 carries sirA under arabinose control, while pBAD33 is
the vector control.
sopB::luxCDABE expression is
higher in the strain carrying pJVR4. The plate shown is an LB plate
that was incubated at 37°C. (D) HilA has no effect on
an flhD::luxCDABE fusion.
14028/pRG38 is an hilA+ strain carrying an
flhD::luxCDABE fusion, while
BA1550/pRG38 is an isogenic hilA mutant. The strains show
equal levels of luminescence, indicating that hilA does not
regulate flhD. The plate shown is a TS motility agar plate
that was incubated at 37°C. (E) SirA represses
flhD in an hilA mutant. BA790 is an hilA
sirA double mutant. The presence of sirA on a
plasmid, pBA322, decreases the expression of the
flhD::luxCDABE fusion on plasmid
pRG38 compared to the vector control, pBAD18-kn. The plate shown is a
TS motility agar plate that was incubated at 37°C.
(F) A csrB::lacZYA
fusion, but not a csrA::lacZYA
fusion, is expressed at lower levels in an sirA mutant (TIM25
versus TIM26 for csrA::lacZYA;
RG235 versus TIM27 for
csrB::lacZYA). The plate shown is
an LB plate that contained X-Gal and that was incubated at
37°C.
|
HilA does not affect the FlhD regulon, and SirA represses flhD independently of hilA. Wild-type S. enterica serovar Typhimurium and an isogenic hilA deletion mutant, both carrying a plasmid-based flhD::luxCDABE fusion, were compared during growth in motility agar (14028/pRG38 versus BA1550/pRG38) (Fig. 1D). Both strains were found to express similar levels of luciferase activity, indicating that hilA does not affect the expression of flhD under these conditions (Fig. 1D). Similar results were obtained with transcriptional fusions to motA (14028/pRG19 versus BA1550/pRG19) (data not shown). These results demonstrate that hilA does not affect the flagellar regulon and strongly suggest that SirA could not regulate the flagellar regulon via hilA. Confirmation of this hypothesis was obtained by examining a plasmid-based flhD::luxCDABE fusion, pRG38, in an arabinose-conditional sirA strain with a deletion in hilA (BA790/pRG38/pBA322). In TS motility agar, this strain produced less light than the vector control strain (BA790/pRG38/pBAD18-kn), demonstrating that SirA is able to repress the flagellar regulon in the absence of hilA (Fig. 1E). Similar results were obtained with an motA::luxCDABE fusion (BA790/pRG19/pBA322 versus BA790/pRG38/pBAD18-kn) (data not shown). The basal level of sirA expression from pBA322 was sufficient to achieve this effect without the addition of arabinose to the media. This methodology also served as a sirA complementation test to demonstrate that the regulatory effects are due to sirA and not to a secondary mutation.
SirA affects a regulatory gene above flhD in the flagellar regulon, csrB. For E. coli, it is known that UvrY (SirA) positively regulates csrB (61). The csrB gene encodes a regulatory RNA that binds to and antagonizes CsrA (45, 57). In E. coli and Salmonella, the CsrA protein is known to positively affect FlhDC expression posttranscriptionally (41, 65). In Salmonella, CsrA also affects the HilA regulon (4, 41). Therefore, we hypothesized that the effect of SirA on flagella could be indirect and due to the regulation of csrB by SirA. Chromosomal merodiploid lacZYA transcriptional fusions to csrA and csrB were constructed and tested for regulation by sirA. The csrA fusion showed no regulation by sirA (TIM25 versus TIM26) (Fig. 1F), but the csrB fusion was activated by sirA (RG235 versus TIM27) (Fig. 1F). These results are consistent with recent findings for E. coli (61).
Purification
and phosphorylation of SirA and BarA198.
Given the complexity of the genetic
networks controlled by SirA, it was imperative to determine which
promoters are bound by SirA and which are only affected indirectly. To
do this, we purified SirA and a soluble portion of BarA to be used in
phosphorylating SirA. Both proteins were tagged with six histidine
residues to facilitate purification by nickel affinity chromatography
essentially as described by Pernestig et al.
(55). The sirA
construct uses the full-length gene and incorporates the six histidine
residues at the C terminus of the protein (pBA416). The barA
construct lacks residues 1 to 198 and contains an N-terminal
His6 tag to form BarA198 (pRG67). Previously, an E.
coli variant of this construct was found to be capable of
transferring phosphate from ATP to SirA and was found to be more
suitable than the wild type for purification because it lacks the two
transmembrane helices found at the N terminus
(55). To confirm that our
SirA-His6 construct was functional in vivo, we
electroporated pBA416 or the vector control pET24a into an
sirA mutant S. enterica serovar Typhimurium
strain carrying an sipC::lacZYA
fusion. His6-tagged sirA fully complemented the
chromosomal sirA mutation and activated the
sipC::lacZYA fusion (BA743/pBA416
versus BA743/pET24a) (data not shown). Purified BarA198
autophosphorylated in the presence of
[
-32P]ATP and transferred phosphate to
SirA (Fig. 2B to
E). The amount of autophosphorylated BarA198 in the reaction steadily
increased for up to 60 min, at which point it maintained a steady-state
level (Fig. 2B and C). The
presence of SDS in the time-zero sample prevented the
autophosphorylation of BarA198 (Fig.
2B and C). The addition of
SirA-His6 to a BarA198 autophosphorylation reaction allowed
BarA198 to transfer phosphate to SirA. Transphosphorylation between
BarA198 and SirA was detectable within 1 min and continued to increase
for 30 min (Fig. 2D and
E). The pool of phosphorylated SirA appeared to be stable
for at least 30 min. SirA did not accept phosphate directly from
[
-32P]ATP in the absence of BarA198, and
the presence of SDS in the time-zero sample prevented
transphosphorylation between SirA and BarA198 (Fig.
2D and E). These results
are consistent with those observed for E. coli
BarA198 and UvrY (SirA)
(55).
![]() View larger version (35K): [in a new window] |
FIG. 2. Purified
BarA198 can autophosphorylate and transfer phosphate to SirA in vitro.
(A) Purified SirA and BarA198 after nickel affinity
chromatography, SDS-PAGE, and Coomassie blue staining. Both proteins
are His6 tagged. Molecular mass markers (Bio-Rad prestained
broad-range standards) are in the center lane (from bottom to top: 7.1,
21, 29, 35, 49, 80, 124, and 209 kDa). SirA-His6 is
predicted to be 24.95 kDa; His6-BarA198 is predicted to be
81.60 kDa. (B) Time course of BarA198 autophosphorylation in
the presence of [ -32P]ATP. Reactions were
allowed to proceed for the times indicated above each lane in minutes
before aliquots were removed and the reactions were stopped by the
addition of sample buffer containing SDS. Samples were
resolved by SDS-PAGE and detected with a PhosphorImager. (C)
Plot of band densities as determined by ImageQuant software from panel
B. (D) Transphosphorylation of SirA by BarA198-P. BarA198
that had been preincubated with [ -32P]ATP
for 25 min was mixed with SirA as indicated. One reaction contained
SirA with [ -32P]ATP and no BarA198.
Reactions were stopped at the times indicated above each lane in
minutes by the addition of sample buffer containing SDS. Samples were
resolved by SDS-PAGE and detected with a PhosphorImager. (E)
Plot of band densities as determined by ImageQuant software from panel
D. P,
phosphorylated.
|
![]() View larger version (58K): [in a new window] |
FIG. 3. SirA
alters the gel mobilities of promoter DNA fragments. Eight promoter DNA
fragments (shown below panels) were tested for their abilities to bind
purified SirA in a gel mobility shift assay. SirA was phosphorylated by
incubation with BarA198 and ATP for 25 min and then was added to
promoter DNA labeled with [ -32P]ATP. Each
reaction was resolved by nondenaturing PAGE, and samples were detected
with a PhosphorImager. The micromolar concentration of SirA in each
reaction is indicated above each lane. An asterisk indicates that a 30-
to 50-fold excess of unlabeled promoter DNA fragment was added to the
reaction as a specific competitor. All reactions contained nonspecific
competitor DNA [2 µg of poly(dI-dC)] and protein (0.2
µg of
BSA).
|
|
|
|---|
-proteobacteria and control
secondary metabolism and virulence functions. However, only in
S. enterica serovar Typhimurium has a systematic
effort been made to identify the entire SirA regulon
(2,
24). The genes identified
can be grouped into two main subregulons, the FlhDC regulon, which
controls motility and chemotaxis (
55 genes), and the HilA
regulon, which controls invasion-associated TTSS-1 (
40 genes).
In this report, we have elucidated the regulatory triad that exists
among SirA, FlhDC, and HilA. Pathways by which their genes are affected
by SirA and promoters that are directly bound by SirA have been
identified. The expression of the FlhDC regulon is decreased in the presence of sirA (24). In this study, we have determined that this repressive effect likely is indirect. The purified SirA protein does not bind the flhDC promoter, but it does bind the csrB promoter. Additionally, a transcriptional fusion to csrB responds to sirA. Therefore, SirA directly activates csrB, which antagonizes the activity of CsrA, which is known to directly affect flhDC (Fig. 4). SirA does not regulate the csrA gene or bind the csrA promoter. These results match those of previous studies of E. coli in which UvrY (SirA) was demonstrated to directly activate a csrB::lacZ fusion in in vitro transcription-translation reactions (61). Therefore, the pathways by which SirA represses flagellar gene expression appear to be similar in E. coli and S. enterica serovar Typhimurium.
![]() View larger version (11K): [in a new window] |
FIG. 4. Model
of the SirA regulatory cascade. SirA directly activates the
csrB, hilA, and hilC promoters. HilA and
HilC activate the invF gene, the product of which activates
genes encoding secreted effectors, including sopB. HilA also
activates genes encoding the structural apparatus of TTSS-1 (data not
shown). The csrB RNA directly binds and antagonizes the
activity of CsrA. CsrA directly increases FlhDC expression
posttranscriptionally. CsrA and fliZ also affect multiple
levels of the HilA regulon through undefined
mechanisms.
|
Phosphotransfer between the E. coli orthologs of BarA and SirA (UvrY) has been demonstrated with purified proteins in vitro (55). We have now demonstrated phosphotransfer between BarA and SirA from a second organism, S. enterica serovar Typhimurium. However, SirA did not require in vitro phosphorylation to bind these promoters. These results are very similar to the results obtained for E. coli, in which UvrY (SirA) was able, without a phosphorylation step, to activate csrB::lacZ in in vitro transcription-translation assays (61). These observations are interesting given the in vivo requirement for BarA or acetylphosphate for SirA activity (5, 42). It is possible that SirA-His6 was already phosphorylated to some extent when purified from E. coli. Alternatively, SirA may bind specific promoter sequences in the absence of phosphorylation but fail to activate transcription until it is phosphorylated. Further studies are required to determine the mechanism of promoter activation by SirA orthologs.
The observation that SirA can directly bind the
hilA promoter is consistent with the adaptor hypothesis, in
which horizontally acquired virulence genes often carry with them a
regulatory locus that is in turn controlled by endogenous housekeeping
sensors (25). Using this
adaptor regulator, the horizontally acquired virulence genes can
immediately tap the extensive sensory apparatus of the host bacterium.
This notion raises the possibility that if SPI1 were to move from
Salmonella into another
-proteobacterium, TTSS-1
might be regulated correctly (unless the new host required activation
at different host locations and/or under different environmental
conditions). Furthermore, it is possible that the SirA binding site in
the hilA promoter evolved in another organism before the
acquisition of SPI1 by Salmonella.
Given that SirA
controls horizontally acquired virulence genes in such a large number
of pathogenic species, it is a potential therapeutic target. A ligand
that could block signal detection by BarA may be sufficient to disrupt
virulence gene expression in numerous pathogens. The nature of the
signal detected by BarA is presently unknown, although several
hypotheses have been proposed. For E. coli, it has
been noted that SirA affects central carbon metabolism, suggesting that
a metabolite may the signal
(54). For L.
pneumophila, it has been observed that ppGpp has no effect on
target genes in the absence of the barA/sirA
orthologs letA/letS, and it was suggested that ppGpp
may be the signal (27).
Interestingly, relA (encoding a ppGpp synthase) appears to be
divergently transcribed from barA in the Salmonella
chromosome. For P. fluorescens, a
dichloromethane-extractable substance in culture supernatants affects
target gene expression, but not in a mutant lacking the predicted
sensor domain of gacS (barA)
(28,
70). If this substance
truly were the signal for BarA, then the implication is that SirA/BarA
is part of a novel quorum-sensing system. Interestingly, for
E. coli and Salmonella (but not for
Pseudomonas), sirA is located downstream of
sdiA, a luxR family member that detects the
N-acylhomoserine lactone production of other microbial species
(1,
51,
60). It will be very
interesting if SdiA and SirA both are found to be quorum-sensing
regulators. Of course, all of these potential signals may affect other
regulators within the same regulatory cascade, and not BarA itself.
Further experimentation is required to determine the signal(s) and
mechanisms by which BarA/SirA orthologs control virulence gene
expression throughout the
-proteobacteria.
We are grateful to Adam Toguchi and Rasika Harshey for constructing and sharing AT351, Bill Metcalf for BW20767, and Cathy Lee for EE638. We are grateful to Irina Artsimovitch for biochemical guidance, John Gunn and Irina Artsimovitch for critical reading of the manuscript, and Jon-David Sears and the OSU fermentation facility for fermentations.
Present
address: Q-One Biotech Ltd., Todd Campus, West of Scotland Science
Park, Glasgow G20 0XA, Scotland. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»